PAVmed(PAVM)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $5.20 (+9.70%), 시가총액 $0.05B, 52주 범위 $0.22 ~ $12.05.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay perform
PAVmed의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
PAVmed의 현재 주가는 $5.20 (+9.70%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
PAVmed의 시가총액은 약 $0.05B입니다.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, dispos